Viracta Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
01 Dec 23 | BuyUS$49,362 | Mark Rothera | Individual | 100,000 | US$0.49 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 13,998 | 0.0356% |
Individual Insiders | 1,132,451 | 2.88% |
Hedge Funds | 3,614,662 | 9.2% |
Institutions | 7,290,287 | 18.6% |
VC/PE Firms | 9,959,759 | 25.4% |
General Public | 17,261,277 | 44% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.2%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
7,392,237 | US$6.1m | 0% | 7.05% | |||
3,614,662 | US$3.0m | 0% | 0.07% | |||
2,567,522 | US$2.1m | -3.65% | 100.0% | |||
1,529,072 | US$1.3m | 0.57% | no data | |||
1,161,280 | US$952.4k | 1.16% | no data | |||
1,154,012 | US$946.4k | -1.73% | 0.06% | |||
782,683 | US$641.9k | 3.33% | no data | |||
689,709 | US$565.6k | 0% | 0.11% | |||
562,995 | US$461.7k | -19.3% | 0.02% | |||
355,460 | US$291.5k | -10.6% | no data | |||
305,652 | US$250.7k | -0.27% | no data | |||
288,571 | US$236.7k | 0% | 0.1% | |||
252,701 | US$207.2k | 0% | no data | |||
178,899 | US$146.7k | 20.7% | no data | |||
168,668 | US$138.3k | 259,000% | no data | |||
102,306 | US$83.9k | 3.53% | no data | |||
100,000 | US$82.0k | 0% | no data | |||
99,375 | US$81.5k | 10% | no data | |||
87,341 | US$71.6k | 45% | no data | |||
74,000 | US$60.7k | 0% | no data | |||
65,867 | US$54.0k | 0% | no data | |||
64,690 | US$53.1k | -33.4% | no data | |||
63,406 | US$52.0k | 0% | no data | |||
48,087 | US$39.4k | 0% | no data | |||
41,412 | US$34.0k | 0% | no data |